A free seminar at the 2014 Genesis Conference focusing on the extensive target screening and compound synthesis resources now available from the European Lead Factory to all European researchers.
Where: Queen Mary Innovation Centre
Location: 42 New Road, E1 2AX, London , United Kingdom
When: Wednesday, 10 December
Time: 14:00
Speakers from pharma, small enterprises and academia will illustrate the significant opportunities for researchers working in drug discovery across all types of organisation – revealing the ways in which state-of-the-art screening and synthesis facilities can be used to kick start drug discovery projects.
These are just some of the topics that will be covered:
- How your library design idea is realised in the European Lead Factory
- Screening targets against the unique high-quality Joint European Compound Library (JECL)
- Extracting rewards from innovative drug targets & library designs
- Partnering with pharmaceutical companies
- Accessing the right resources and expertise
- Protecting your IP
- The route to commercialisation
- Staying free to pursue your research interests
This is a first class opportunity to think about your target assay development and library design plans, with a panel able to answer questions on the wider role of crowd sourced innovation and on working within extended public-private partnerships.
Agenda:
14:00 – Welcome: The European Lead Factory
Dr. Dimitrios Tzalis, European Lead Factory Head of Chemistry and CEO, Taros
Chemicals GmbH Co KG
14:10- Shared innovation from the perspective of Big Pharma
Dr. Stefan Jaroch, Head of External Innovation Technology, Bayer Pharma AG
14:40 – Interactive round table: Challenges when innovating in drug discovery
Dr. Ton Rijnders (Moderator), European Lead Factory Head European Screening
Centre and Scientific Director TI Pharma
Dr. Helma Rutjes, European Lead Factory Assay Development Leader and Head of
Assay Development PPSC
Dr. Wen Hwa Lee, Strategic Alliances Manager, SGC-University of Oxford
Dr. Rogier Buijsman, Head of Chemistry and Managing Director of the Netherlands
Translational Research Center BV (NTRC), Selected Target Programme Owner
15:30 – Networking session: One-on-one sessions and specific conversations with interested candidates (submission of proposals target assays & library design proposals)
For further details, see 'more information', below.
To register, select 'book now', top right.
Where: Queen Mary Innovation Centre
Location: 42 New Road, E1 2AX, London , United Kingdom
When: Wednesday, 10 December
Time: 14:00
Speakers from pharma, small enterprises and academia will illustrate the significant opportunities for researchers working in drug discovery across all types of organisation – revealing the ways in which state-of-the-art screening and synthesis facilities can be used to kick start drug discovery projects.
These are just some of the topics that will be covered:
- How your library design idea is realised in the European Lead Factory
- Screening targets against the unique high-quality Joint European Compound Library (JECL)
- Extracting rewards from innovative drug targets & library designs
- Partnering with pharmaceutical companies
- Accessing the right resources and expertise
- Protecting your IP
- The route to commercialisation
- Staying free to pursue your research interests
This is a first class opportunity to think about your target assay development and library design plans, with a panel able to answer questions on the wider role of crowd sourced innovation and on working within extended public-private partnerships.
Agenda:
14:00 – Welcome: The European Lead Factory
Dr. Dimitrios Tzalis, European Lead Factory Head of Chemistry and CEO, Taros
Chemicals GmbH Co KG
14:10- Shared innovation from the perspective of Big Pharma
Dr. Stefan Jaroch, Head of External Innovation Technology, Bayer Pharma AG
14:40 – Interactive round table: Challenges when innovating in drug discovery
Dr. Ton Rijnders (Moderator), European Lead Factory Head European Screening
Centre and Scientific Director TI Pharma
Dr. Helma Rutjes, European Lead Factory Assay Development Leader and Head of
Assay Development PPSC
Dr. Wen Hwa Lee, Strategic Alliances Manager, SGC-University of Oxford
Dr. Rogier Buijsman, Head of Chemistry and Managing Director of the Netherlands
Translational Research Center BV (NTRC), Selected Target Programme Owner
15:30 – Networking session: One-on-one sessions and specific conversations with interested candidates (submission of proposals target assays & library design proposals)
For further details, see 'more information', below.
To register, select 'book now', top right.
